Finns with normal fasting plasma glucose and glycated haemoglobin concentrations. Each subject received a euglycaemic hyperinsulinaemic insulin clamp (insulin infusion rate 1 mU-kg -1. min-1). The glucose infusion rate required to maintain normoglycaemia between 20-120 min was used as the measure of whole body insulin sensitivity. Unpublished data and data from references [25, 31, 105, [121] [122] [123] Variation in insulin action in normal subject~"
Simply knowing the age and degree of relative obesity (body mass index) is insufficient to explain more than -35 % of the variability in insulin action in normal people ( Fig. 1) , even when insulin sensitivity is quantitated using the gold standard technique, the euglycaemic insulin clamp [17] , in the same laboratory in one homogenous ethnic group such as the Finns (Fig. 1) .
Physical fitness. The close correlation between maximal aerobic power (VO2max) and whole body insulin sensitivity is well known [18, 20] , but often neglected [13] [14] [15] [16] . For example, after considering VO2max as a confounding variable, no significant differ from the other two groups by their high percent muscle of body weight, while the runners (N) have a higher VO2max than either the weight lifters or the control subjects ( 9 *p < 0.05 or less vs other groups. Glucose uptake per kg of body weight (lower left panel) is increased in both weight lifters and runners compared to untrained subjects, while glucose uptake expressed per kg muscle tissue, is only increased in the runners. Adapted with permission from reference [25] [21] or a marginally significant [22] deterioration in insulin action at physiological insulin concentrations was found in patients with essential hypertension in two recent studies (Fig. 2 ). Of course, hypertension per se might worsen VO2max and thereby insulin action, but these studies emphasize the need at least to consider known determinants of insulin sensitivity.
Recently, it was also demonstrated that smokers are more insulin resistant than non-smokers [13] . Whether this is due to some component of cigarette smoke per se or to physical inactivity, which one intuitively might predict to be more frequent among smokers than non-smokers, remains to be tested. Regarding insulin resistance in relatives of patients with NIDDM, VO2max has been measured in two studies [23, 24] . In the Pima Indians, insulin resistance appears familial and independent of physical fitness [23] while in a recent study in Caucasians [24] , relatives of patients with NIDDM were not resistant after controlling for physical fitness. These data suggest that one may have to reconsider the idea that insulin resistance is a familial or genetic trait independent of physical fitness in NIDDM.
Body composition. Since muscle tissue is the major target for insulin-stimulated glucose disposal, a high muscle mass enhances glucose utilization [25] and glucose tolerance [26] independent of physical fitness (Fig. 2) . To control for this confounding variable in studies aimed at defining primary defects in NIDDM, the fat free or muscle mass should be determined.
Gender. (Fig.3) , one may ask whether the differences in regional fat distribution, obesity and physical fitness could account for racial differences in insulin sensitivity.
Location of defects in insulin action in vivo
Under basal and postprandial hyperglycaemic conditions, the absolute rate of glucose utilization is normal in NIDDM [51] because hyperglycaemia compensates by glucose mass-action for peripheral insulin resistance [1] , and hyperglycaemia cart be attributed to excessive basal hepatic glucose production and its impaired suppression postprandially [52, 53] . However, if glucose uptake is measured under conditions where glucose and insulin concentrations are identical in non-diabetic and diabetic individuals, a major defect in glucose uptake is observed. The ensuing discussion is focused on critically examining at-H. Yki-Jfirvinen: Insulin resistance and NIDDM 
Control IDDM subjects
Glucose uptake altered by insulin resistance Glucose uptake not altered by insulin resistance Fig.4 . Components of glucose uptake. During hyperinsulinaemia (serum insulin -100 mU/1), the component of glucose uptake not altered by insulin resistance ( [] ) includes non-insulin-dependent glucose oxidation, such as that which occurs in the brain (-i mg. kg -1 9 min -1) [55-58], and insulin-sensitive glucose oxidation which does not become insulin resistant such as that which occurs in the heart (-0.5 rag. kg -1 . min -1) [62] . The other component of glucose uptake, which is altered by insulin resistance includes non-oxidative glucose disposal [59] , and some fraction of oxidative glucose disposal (the sum of the black and the hatched bars). Data for control subjects and IDDM patients adapted with permission from reference [73] . *** p < 0.001 tempts to localize the defect in glucose utilization to non-oxidative (predominantly glucose storage) and oxidative pathways of glucose metabolism.
Glucose oxidation and storage. In vivo, the rate of glucose utilization is commonly determined using the euglycaemic insulin clamp technique combined with an infusion of [3-3H] glucose [54] . If glucose oxidation is simultaneously determined using indirect calorimetry, the rate of non-oxidative glucose disposal can be calculated by subtracting the rate of glucose oxidation from total glucose utilization [54] . One may then calculate the percent of total glucose utilization that is disposed oxidatively and non-oxidatively. When such calculations are applied to compare insulin-resistant individuals and normal subjects, it is usually found that the rate of non-oxidative glucose disposal, a measure of glycogen synthesis (glucose storage), is more reduced than the oxidative component [15] . Such findings have been interpreted to indicate that insulin resistance is localized to pathways of glycogen synthesis. However, three factors need to be considered before dogmatically accepting this conclusion. Total glucose utilization (rag. kg 1. min q) Fig. 5 . Percent of glucose stored calculated from insulin-sensitive glucose uptake (-e-) and from total glucose uptake (-O-). If calculated by dividing the rate of glucose oxidation by total glucose disposal without considering the component of glucose oxidation that is not decreased by insulin resistance, the percent glucose stored will decrease as a function of total glucose uptake even if it is constant, as assumed in this example. Adapted with permission from reference [64] not seem to become insulin-resistant [21, 62] . These two fixed components decrease the relative amount of glucose stored in insulin-resistant individuals even when the relative reductions in glucose oxidation and storage are similar (Figs. 4 and 5) . Third, when glucose uptake is determined at high physiological insulin concentrations, glucose oxidation is quantitatively less important than glucose storage. The likelihood of missing a defect in glucose oxidation is therefore greater for glucose oxidation than storage. The net effect of these three factors is that glucose storage will always be more affected in insulin-resistant individuals, and that the likelihood of detecting a defect in insulin-stimulated glucose oxidation is much lower than that of detecting a defect in non-oxidative glucose disposal. To more reliably estimate the contribution of defects in glucose oxidation and storage to decreases in whole body glucose disposal, the fraction of glucose oxidation which is either insulin-independent or not affected by insulin resistance, needs to be estimated. One possibility is to determine glucose oxidation in the basal state, and consider this rate to represent non-insulin-dependent glucose oxidation [63, 64] . This approach has two limitations. First, a small proportion of basal glucose oxidation is insulin-dependent [65] , and second, the presence of insulin-sensitive glucose oxidation, which is not influenced by insulin resistance will be neglected. Even so, by subtracting basal glucose oxidation from glucose oxidation during hyperinsulinaemia, Del Prato et al. [63] found that the percent of glucose oxidized and stored of total glucose disposal was similar between patients with NIDDM and control subjects. The best way theoretically is to measure glucose oxidation directly using local indirect calorimetry across muscle tissue, which is the quantitatively most important location for insulin-stimulated glucose utilization [54] .
Using this technique, Kelley et al. [19] found that patients with NIDDM oxidized 50 % less glucose than matched non-diabetic subjects under normoglycaemic hyperinsulinaemic conditions. This relative reduction in glucose oxidation is appreciably higher than that found in studies using indirect calorimetry [15, 59, 66] . In insulin-dependent (IDDM) patients, the percent glucose oxidized and stored is similar to that in non-diabetic patients, assuming brain glucose oxidation to be i mg 9 kg -1 9 min -1, and heart glucose uptake (0.5 mg-kg -a-min -1, [62] ) to consist of glucose oxidation [60] . These data imply that there is a need to reconsider the glycogen synthetic pathway as the predominant location of insulin resistance. Of course, even if the percent of glucose oxidized and stored is similar in insulin-resistant and sensitive individuals, this does not exclude the possibility that defects along the glycogen synthetic pathway cause insulin resistance, but does indicate that such a defect will induce a rate-limiting defect at the level of glucose transport or phosphorylation.
Glucose extraction and blood flow. Limb glucose uptake can be determined using the Fick principle by multiplying the glucose arterio-venous (AV) difference by blood flow. In normal subjects, insulin rapidly increases the glucose AV-difference, a measure of cellular glucose extraction, to its maximum (Fig. 6) [67] . Insulin also increases blood flow but this effect of insulin differs from stimulation of glucose extraction in two important ways. First, stimulation of blood flow requires higher, supraphysiological plasma insulin concentrations than stimulation of glucose extraction [68, 69] , (Fig. 6) . Second, the response of blood flow to insulin is gradual and reaches maximum after several hours of insulin stimulation, while glucose extraction is maximal within 30 to 90 min [68, 69] . Based on this physiological knowledge, one may predict that variation in insulin action in normal subjects is more likely to be attributable to blood flow at supraphysiological than physiological insulin concentrations while differences in glucose extraction distinguish between sensitive and insensitive individuals under physiological conditions. Abundant experimental evidence indicates that this indeed is the case. Thus, defects in insulin action on blood flow have been described in both obese subjects [68] , and patients with IDDM [70] , NIDDM [71] and essential hypertension [72] , when glucose uptake has been measured during high-dose insulin infusions lasting up to 9 h. On the other hand, during short-term insulin infusions lasting 2-3 h, defects in glucose uptake are due to defects in glucose extraction in obese subjects [40] , and patients with IDDM [73] , NIDDM [74, 75] and essential hypertension [76] .
A fundamental question regarding defects in insu~ lin stimulation of blood flow is whether such defects are indeed responsible for the decrease in glucose up- Baron et al. [77] infused metacholine into the femoral artery of healthy volunteers and observed significant increases in both blood flow and leg glucose uptake. In contrast, Natali et al. [78] infused adenosine into the brachial artery but found no enhancement in glucose uptake despite a significant increase in blood flow. In this study, the increase in flow was entirely counterbalanced by a significant decrease in the glucose AV-difference.
Is there a familial or genetic defect in insulin action in relatives of patients with "common' NIDDM?
A positive family history is the single most important factor, independent of physical fitness and obesity, in determining susceptibility to NIDDM [10, 46, [79] [80] [81] [82] . It has recently been proposed, in cross-sectional studies, that individuals with a positive family history for NIDDM are more insulin resistant than those with a negative family history, and that insulin resistance may be genetically determined in such individuals [15, [83] [84] [85] . Some potential shortcomings of these studies should be considered before pursuing the hypothesis that insulin resistance is the primary abnormality predisposing to NIDDM. The studies included a small number of relatives (13 to 20) , and in none of the studies were all parameters, especially intra-abdominal fat and maximal aerobic power, which profoundly influence insulin action in normal subjects, determined. This would seem important particularly when a small number of subjects is studied, to H. Yki-Jfirvinen: Insulin resistance and NIDDM accurately control for known causes of variation in insulin action, and to avoid recruitment bias. Furthermore, in the study in which identical twins discordant for NIDDM were studied, an insulin secretory defect and normal insulin sensitivity was found in twins with normal glucose tolerance [84] . Insulin sensitivity was impaired only in the twins with impaired glucose tolerance [84] . In a recent study by Banerji et al. [49] , where intra-abdominal fat mass was determined using CT scanning in normoglycaemic black NIDDM men, whole body insulin sensitivity was strongly inversely (r = -0.81) related to intra-abdominal fat (Fig. 3) but not to body mass index or adipose tissue volume, and only weakly related to the waistto-hip ratio (r = -0.49). It was proposed that insulin resistance in black NIDDM men is exclusively a consequence of increased intra-abdominal adipose tissue mass. In Pima Indians [23] , insulin resistance is a familial characteristic which is not explained by gender, age, body mass index or physical fitness. The Pima Indians, who have the highest prevalence of NIDDM in the world [86] [87] . Whether the same would be true for Mexican Americans who have a positive family history of NIDDM is presently unknown. Another argument, not explored in detail here, which questions the role of insulin resistance as a primary genetic defect in the pathogenesis of NIDDM, is the evidence gathered in over 20 prospective studies. These studies have demonstrated that insulin resistance only predicts NIDDM in individuals with a low acute insulin response [8, 9, 81, [88] [89] [90] , even in extremely insulin-resistant populations such as the Pima Indians [89] . Furthermore, in prospective studies both insulin resistance [3, 4, 6, 8-10, 79, 81, 89-92] , and markers of insulin resistance such as obesity [7, 9, 10, 81, 82, [88] [89] [90] [91] [92] [93] [94] [95] [96] [97] [98] [99] [100] , abdominal fat distribution [4, 6, 89, 94] , physical inactivity [80, 81, 95, 97, 99] , a low sex-hormone-binding globulin concentration [4, 92] and macrovascular disease [81, 90] , as welt as insulin-secretory defects [5, 8, 9, 81, 88, 89, 91] have predicted NIDDM.
A problem in the prospective studies is that insulin secretory defects can only be accurately compared between two groups if the groups are matched for factors which affect insulin secretion. Since subjects who develop NIDDM are usually more obese, physi- cally inactive and insulin resistant than those who do not, comparison of insulin secretion has to be done using statistical procedures that adjust for differences between individuals with and without a positive family history. This approach is unlikely to be as accurate as study of carefully matched groups, because it assumes a linear relationship between insulin secretion and sensitivity. In a recent cross-sectional study, which included 100 volunteers of European ancestry, individuals with and without a first-degree NIDDM relative were carefully matched for age, body mass index, gender and the waist-to-hip ratio. It was found that those with a positive family history for NIDDM were equally sensitive as those with a negative family history, but had diminished first and second phase insulin release as determined by the hyperglycaemic clamp technique (Fig.7 ) [101] . Even these data should be interpreted with Caution. First, in Caucasians, patients with late-onset IDDM may erroneously be classified as having NIDDM [102] . Second, the matching of study subjects makes insulin resistance look unimportant in the pathogenesis of NIDDM although it clearly is an important risk factor for developing NIDDM, according to the prospective studies. Third, even in this study abdominal fat mass and VO2max were not determined. This may, however, be of lesser concern than in the previous studies [15, 84, 85] since a large number of subjects was studied and no difference in insulin sensitivity was found. On one occasion, saline (NaC1) was infused, on the other 10 % glucose was infused to increase plasma glucose to -17 mmol/1. The following day (Fig. 9) , forearm glucose uptake was determined under similar conditions of glycaemia and insulinaemia. Reproduced with permission from reference [116] Glucose toxicity -the common acquired cause of insulin resistance in IDDM and NIDDM
In any type of diabetes, NIDDM [103] , IDDM [104, 105] or pancreatogenic [106] , insulin sensitivity is impaired compared to matched non-diabetic individuals. In patients with IDDM, insulin sensitivity is normal if glycaemic control is normal, as in patients who are in clinical remission [107] , or in whom glycaemic control has been normalized by intensive insulin therapy [108] [109] [110] . The normalization of insulin sensitivity during intensive insulin therapy is observed in the face of unchanged or diminished insulin requirements and free insulin concentrations [108] [109] [110] suggesting that factors other than insulin deficiency contribute to normalization of insulin sensitivity. In patients with NIDDM, any intervention which lowers plasma glucose concentrations seems to improve insulin sensitivity [111] . The degree of insulin resistance is inversely correlated with average glycaemic control in both patients with NIDDM [2, 112, 113] and IDDM [105, 114] . Direct proof of the ability of hyperglycaemia per se to induce insulin resistance has been obtained in studies in patients with IDDM [115, 116] as well as in studies performed in diabetic 
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'T e-20 ~' _'E glycaemia glycaemia Fig.9 . Forearm glucose AV-difference and blood flow after 24 h of hyperglycaemia and after 24 h of normoglycaemia (see Fig. 8 ). Exposure to hyperglycaemia decreased forearm glucose uptake significantly due to a decrease in glucose extraction (*p < 0.05 for hyper-vs normoglycaemia) rats [117, 118] . In IDDM, simply increasing the glucose concentration for 24 h is sufficient to induce insulin resistance in skeletal muscle [115, 116] (Figs. 8  and 9 ). In mildly diabetic rats, selective treatment of hyperglycaemia with phlorizin, which normalizes plasma glucose concentrations without changing plasma insulin concentrations, via inhibition of glucose reabsorption in the proximal tubuli, normalizes insulin sensitivity [117] and secretion [118] . The ability of hyperglycaemia itself to impair both insulin sensitivity and secretion has been referred to as 'glucose toxicity' [1, 111, 119] . The glucose toxicity concept has widespread implications for both the pathophysiology and treatment of NIDDM. First, as hyperglycaemia itself self-perpetuates the diabetic state, it may significantly contribute to the natural course of NIDDM, which is characterized by gradual loss of insulin secretion and progressive impairment in insulin sensitivity [2] . Furthermore, hyperglycaemia might also contribute to the transition from impaired to diabetic glucose tolerance.
Regarding treatment of hyperglycaemia, it is wellestablished that every intervention be it diet, weight loss, inhibition of glucose absorption by acarbose or hepatic glucose production by metformin, stimulation of insulin secretion by sulfonylureas improves both glycaemia and insulin sensitivity [111] . Since glycaemia itself is a determinant of insulin sensitivity, concepts such as the existence of direct extrapancreatic effects of antihyperglycaemic agents can be questioned. Indeed, the current consensus seems to be that such direct effects are unlikely to be of clinical significance [120] .
Conclusion
The above discussion illustrating the multitude of variables which influence insulin sensitivity in normal subjects challenges the prevailing view that insulin sensitivity is genetically determined in patients with NIDDM. The lack of accurate quantitation of all determinants of insulin sensitivity in the cross-sectional studies, and the difficulty in distinguishing between insulin secretion and sensitivity in prospective studies implies that the inherited metabolic abnormality in NIDDM still remains to be defined. The methodological difficulties in assessing the fate of glucose in many insulin-resistant states raise the possibility that defects in glycogen synthesis may not be rate-limiting for insulin action. It seems more likely that defects in glucose transport or phosphorylation are rate-limiting for glucose disposal, and thus represent either the primary regulatory steps or the steps via which distal defects signal their influence on glucose uptake.
The above considerations should not be interpreted to suggest that insulin resistance is unimportant in the pathogenesis of NIDDM. It clearly increases the risk of developing NIDDM, and more importantly, its early amelioration by lifestyle modification seems sufficient to prevent NIDDM [81] . 
